The prognosis for patients with meningiomas, the most common tumors of the brain and spinal cord, has improved in the decades since advanced imaging began aiding detection. 

A generic equivalent to Gleevec, imatinib mesylate tablets that treat chronic myeloid leukemia, will now be available in the U.S. for multiple purposes approved by the U.S. Food and Drug Administration.

Diagnosing strains of liver cancer can be difficult because they are usually simila, but physicians have various tools to help them. Now, new research at Washington University has found these approaches may not always be accurate.

Radiotherapy, a process designed to cure cancer by destroying cancerous tumors, can be harmful to patients if it targets the wrong areas. It is also can be difficult to manage. But new research found a method to perform selective radiotherapy, which can reduce toxicity in the body.

Electronic cigarettes contain two previously undiscovered probable carcinogens in their vapor, according to a study in the journal Environmental Science and Technology.

A pilot study using MRI as the primary screening test for prostate cancer has shown the imaging modality better at predicting the disease than popular—yet controversial—prostate-specific antigen (PSA) blood testing. 

A team of Harvard radiologists is advising fellow rads to bone up on imaging-evident drug toxicity so as to shed their reputation as providers of a standalone service and, more to the point, cement their role as central members of the cancer team in this era of precision oncology. 

Potential lung cancers that show up as nonsolid nodules (NSNs) are innocuous enough that they can be appropriately managed by annual low-dose CT scans in lieu of immediate biopsy or treatment, according to a study published July 5 in Radiology.